These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 8456315)

  • 21. Peptide synthesis catalyzed by an antibody containing a binding site for variable amino acids.
    Hirschmann R; Smith AB; Taylor CM; Benkovic PA; Taylor SD; Yager KM; Sprengeler PA; Benkovic SJ
    Science; 1994 Jul; 265(5169):234-7. PubMed ID: 8023141
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Modeling the catalysis of anti-cocaine catalytic antibody: competing reaction pathways and free energy barriers.
    Pan Y; Gao D; Zhan CG
    J Am Chem Soc; 2008 Apr; 130(15):5140-9. PubMed ID: 18341277
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Binding specificity of hydrolytic catalytic antibody: lessons from the diverse immune system.
    Wada Y; Ono M
    J Protein Chem; 1999 Feb; 18(2):199-204. PubMed ID: 10333294
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Selective chemotherapeutic strategies using catalytic antibodies: a common pro-moiety for antibody-directed abzyme prodrug therapy.
    Kakinuma H; Fujii I; Nishi Y
    J Immunol Methods; 2002 Nov; 269(1-2):269-81. PubMed ID: 12379367
    [TBL] [Abstract][Full Text] [Related]  

  • 25. First-principle studies of intermolecular and intramolecular catalysis of protonated cocaine.
    Zhan CG; Deng SX; Skiba JG; Hayes BA; Tschampel SM; Shields GC; Landry DW
    J Comput Chem; 2005 Jul; 26(10):980-6. PubMed ID: 15880781
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The elicitation of carboxylesterase activity in antibodies by reactive immunization with labile organophosphorus antigens: a role for flexibility.
    Schowen RL
    J Immunol Methods; 2002 Nov; 269(1-2):59-65. PubMed ID: 12379352
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The concept of pharmacologic cocaine interception as a treatment for drug abuse.
    Gao Y; Orson FM; Kinsey B; Kosten T; Brimijoin S
    Chem Biol Interact; 2010 Sep; 187(1-3):421-4. PubMed ID: 20219449
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Efficient screening for catalytic antibodies using a short transition-state analog and detailed characterization of selected antibodies.
    Takahashi N; Kakinuma H; Hamada K; Shimazaki K; Takahashi K; Niihata S; Aoki Y; Matsushita H; Nishi Y
    Eur J Biochem; 1999 Apr; 261(1):108-14. PubMed ID: 10103040
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identification of a cocaine esterase in a strain of Pseudomonas maltophilia.
    Britt AJ; Bruce NC; Lowe CR
    J Bacteriol; 1992 Apr; 174(7):2087-94. PubMed ID: 1551831
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A novel monoclonal antibody specific for cocaine.
    Nakayama H; Kenjyou N; Shigetoh N
    Monoclon Antib Immunodiagn Immunother; 2013 Aug; 32(4):262-4. PubMed ID: 23909419
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Aspects of antibody-catalyzed primary amide hydrolysis.
    Titmas RC; Angeles TS; Sugasawara R; Aman N; Darsley MJ; Blackburn G; Martin MT
    Appl Biochem Biotechnol; 1994; 47(2-3):277-90; discussion 291-2. PubMed ID: 7944343
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cocaine benzoyl thioester: synthesis, kinetics of base hydrolysis, and application to the assay of cocaine esterases.
    Cashman JR; Berkman CE; Underiner G; Kolly CA; Hunter AD
    Chem Res Toxicol; 1998 Aug; 11(8):895-901. PubMed ID: 9705751
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Development of monoclonal antibodies directed against cocaine and cocaethylene: potential new tools for immunotherapy.
    Danger Y; Devys A; Gadjou C; Galons H; Blanchard D; Folléa G
    Hybrid Hybridomics; 2004 Aug; 23(4):212-8. PubMed ID: 15319068
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Chemical modification of a catalytic antibody that accelerates the hydrolysis of carbonate esters.
    Suzuki H; Higashi Y; Naitoh N; Yamamoto C; Nakamura S; Kawamura-Konishi Y
    J Protein Chem; 2000 Jul; 19(5):419-24. PubMed ID: 11131148
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Reward and Toxicity of Cocaine Metabolites Generated by Cocaine Hydrolase.
    Murthy V; Geng L; Gao Y; Zhang B; Miller JD; Reyes S; Brimijoin S
    Cell Mol Neurobiol; 2015 Aug; 35(6):819-26. PubMed ID: 25814464
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immunotherapy for cocaine addiction.
    Landry DW
    Sci Am; 1997 Feb; 276(2):42-5. PubMed ID: 9000762
    [No Abstract]   [Full Text] [Related]  

  • 37. Augmenting the efficacy of anti-cocaine catalytic antibodies through chimeric hapten design and combinatorial vaccination.
    Wenthur CJ; Cai X; Ellis BA; Janda KD
    Bioorg Med Chem Lett; 2017 Aug; 27(16):3666-3668. PubMed ID: 28709828
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cocaine metabolism: cocaine and norcocaine hydrolysis by liver and serum esterases.
    Stewart DJ; Inaba T; Lucassen M; Kalow W
    Clin Pharmacol Ther; 1979 Apr; 25(4):464-8. PubMed ID: 428191
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cocaethylene metabolism and interaction with cocaine and ethanol: role of carboxylesterases.
    Laizure SC; Mandrell T; Gades NM; Parker RB
    Drug Metab Dispos; 2003 Jan; 31(1):16-20. PubMed ID: 12485948
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Controlled release of anti-cocaine catalytic antibody from biodegradable polymer microspheres.
    Homayoun P; Mandal T; Landry D; Komiskey H
    J Pharm Pharmacol; 2003 Jul; 55(7):933-8. PubMed ID: 12906750
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.